Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2020-08-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$417.6m
reported value
+13.1% vs Q1 2020
16positions
89.1%in top 10
9 new
0 added
4 reduced
9 sold out
vs Q1 2020
Holdings, Q2 2020
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CONSTELLATION PHARMCETICLS I CNST | $120.7m28.90% | Unchanged |
| TRILLIUM THERAPEUTICS INC TR | $54.9m13.15% | Unchanged |
| ALTIMMUNE INC ALT | $48.2m11.54% | New |
| RELMADA THERAPEUTICS INC RLMD | $29.9m7.16% | Reduced -174.4k |
| SURFACE ONCOLOGY INC SURF | $25.4m6.09% | New |
| KEROS THERAPEUTICS INC KROS | $25.2m6.04% | New |
| VAXART INC VXRT | $24.5m5.86% | New |
| MYOVANT SCIENCES LTD MYOV | $17.4m4.17% | New |
| MARINUS PHARMACEUTICALS INC MRNS | $14.5m3.48% | Reduced -776.3k |
| INARI MED INC NARI | $11.4m2.73% | New |
| KURA ONCOLOGY INC KURA | $9.4m2.24% | New |
| SYNDAX PHARMACEUTICALS INC SNDX | $9.3m2.22% | New |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $8.5m2.05% | Unchanged |
| ADAPTIMMUNE THERAPEUTICS PLC ADAPY | $7.8m1.87% | New |
| 89BIO INC ETNB | $5.8m1.39% | Reduced -661.1k |
| SIERRA ONCOLOGY INC COM NEW | $4.6m1.10% | Reduced -112.1k |
Sold out since Q1 2020
| Security | Value then |
|---|---|
| AXSOME THERAPEUTICS INC AXSM | $47.7m810.0k shares |
| INOVIO PHARMACEUTICALS INC | $21.6m2.9m shares |
| 10X GENOMICS INC TXG | $18.7m300.0k shares |
| MERSANA THERAPEUTICS INC | $15.3m2.6m shares |
| VERASTEM INC | $9.8m3.7m shares |
| ADVERUM BIOTECHNOLOGIES INC | $9.7m994.4k shares |
| IVERIC BIO INC OPHT | $8.9m2.6m shares |
| SPERO THERAPEUTICS INC SPRO | $3.8m474.0k shares |
| PROTAGONIST THERAPEUTICS INC PTGX | $799.0k113.1k shares |